Emerging Approaches to Stabilizing Animal Infectious Disease Vaccines
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 14
Special Issue Editor
Interests: animal infectious disease; zoonotic disease; vaccine delivery; nanoparticles; adjuvants; stabilization; innate and adaptive immune response
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccination remains central to controlling infectious diseases in animals and mitigating the risk of zoonotic transmission. The effectiveness of vaccines, whether live attenuated, inactivated, or subunit, relies largely on their stability. Various drying techniques, such as lyophilization and spray drying, have been developed to produce dry formulations, thereby enhancing stability. For liquid vaccines, stabilizing excipients, including sugars, polymers, salts, adjuvants, and novel delivery systems such as nanoparticles and vectors, have been employed. Additionally, significant efforts are being made to create ambient-stable vaccines that can eliminate the need for cold-chain logistics.
Given the continual emergence of infectious and zoonotic pathogens, advancing the development of stable vaccines has become increasingly critical. This Special Issue seeks submissions that present innovative methodologies and emerging approaches for enhancing the stability of vaccines targeting animal infectious diseases.
Dr. Sankar Renu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stabilization
- liquid and dry formulations
- drying techniques
- lyophilization
- stabilizing additives
- nanoparticles
- viral vectors
- adjuvants
- vaccines
- animal infectious diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
